SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-24-010477
Filing Date
2024-08-14
Accepted
2024-08-14 06:13:53
Documents
9
Period of Report
2024-08-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K fsd_6k.htm 6-K 11722
2 FINANCIAL STATEMENTS fsd_ex991.htm EX-99.1 825591
3 MDA fsd_ex992.htm EX-99.2 344304
4 CEO CERTIFICATE fsd_ex993.htm EX-99.3 2013
5 CFO CERTIFICATE fsd_ex994.htm EX-99.4 1559
6 fsd_ex993img1.jpg GRAPHIC 221685
7 fsd_ex993img2.jpg GRAPHIC 48371
8 fsd_ex994img1.jpg GRAPHIC 221736
9 fsd_ex994img2.jpg GRAPHIC 47889
  Complete submission text file 0001654954-24-010477.txt   1929929
Mailing Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4
Business Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4 (416) 854-8884
FSD Pharma Inc. (Filer) CIK: 0001771885 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39152 | Film No.: 241203954
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)